Tue, 21 June 2016
This week I spoke with Kevin Sayer, CEO of Dexcom about the American Diabetes Association's 2016 Scient Sessions, advancements and upgrades in development for Dexcom's users, the potential and pressure of artificial pancreas technology, and the impact of patient feedback on Dexcom's design.
For more information about Dexcom, visit dexcom.com.
Run Time - 35:50
Send your feedback to firstname.lastname@example.org.